KR890005269A - 재조합 아비폭스비루스 - Google Patents

재조합 아비폭스비루스 Download PDF

Info

Publication number
KR890005269A
KR890005269A KR1019880012033A KR880012033A KR890005269A KR 890005269 A KR890005269 A KR 890005269A KR 1019880012033 A KR1019880012033 A KR 1019880012033A KR 880012033 A KR880012033 A KR 880012033A KR 890005269 A KR890005269 A KR 890005269A
Authority
KR
South Korea
Prior art keywords
recombinant
abipoxvirus
cdna
base sequence
poultry
Prior art date
Application number
KR1019880012033A
Other languages
English (en)
Other versions
KR970000530B1 (ko
Inventor
노보루 야나기다
사끼꼬 사에끼
료헤이 오가와
고우이찌 가모가와
요시유끼 하야시
가즈나리 사와구찌
Original Assignee
다끼사와 다께시
닛뽕제온 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 다끼사와 다께시, 닛뽕제온 가부시끼가이샤 filed Critical 다끼사와 다께시
Publication of KR890005269A publication Critical patent/KR890005269A/ko
Application granted granted Critical
Publication of KR970000530B1 publication Critical patent/KR970000530B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

내용 없음

Description

재조합 아비폭스비루스
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도, 제2도 및 제3도는 재조합 아비폭스비루스의 재작과정을 나타낸다.

Claims (6)

  1. 아미폭스비루스의 증식에 비-필수적인 게놈 영역에 뉴우켓슬병 비루스-유래 혈구 응집소 뉴우라미니다제를 코딩하는 cDNA의 전부 또는 일부를 삽입시킨 재조합 아비폭스비루스.
  2. 제1항에 있어서,cDNA가 프로모터의 통제하에 있는 재조합 아비폭스비루스.
  3. 제1항 또는 제2항에 있어서, cDNA가 제4도에 나타낸 아미노산 서열 또는 그 아미노산 서열과 실질적으로 동일한 기능을 갖는 폴리펩티드를 코딩하는 재조합 아비폭스비루스.
  4. 제1항 또는 제2항에 있어서, cDNA가 제4도에 나타낸 염기 서열 또는 그 염기 서열과 실질적으로 동일한 기능을 갖는 염기 서열을 갖는 재조합 아비폭스비루스.
  5. 제1항 내지 제4항중 어느 한 항의 재조합 아비폭스비루스를 함유하는 가금용 백신.
  6. 제1항 또는 제2항의 재조합 아비폭스비루스를 함유하는 가금에게 포울폭스 비루스 및 뉴유켓슬병 비루스에 대한 항-비루스 면역성을 부여할수 있는 가금용 백신.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019880012033A 1987-09-16 1988-09-16 재조합 아비폭스비루스 KR970000530B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP231653/87 1987-09-16
JP23165387 1987-09-16
JP62-231653 1987-09-16

Publications (2)

Publication Number Publication Date
KR890005269A true KR890005269A (ko) 1989-05-13
KR970000530B1 KR970000530B1 (ko) 1997-01-13

Family

ID=16926866

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880012033A KR970000530B1 (ko) 1987-09-16 1988-09-16 재조합 아비폭스비루스

Country Status (5)

Country Link
EP (1) EP0308220B1 (ko)
KR (1) KR970000530B1 (ko)
AU (1) AU611711B2 (ko)
CA (1) CA1340203C (ko)
DE (1) DE3850019T2 (ko)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0414689B1 (en) * 1988-02-12 1994-12-07 Commonwealth Scientific And Industrial Research Organisation Pox virus vectors
DE3813093A1 (de) * 1988-04-19 1989-11-09 Immuno Ag Rekombinantes plasmid, verfahren zum herstellen eines rekombinanten avipoxvirus, rekombinantes avipoxvirus und dessen verwendung
US5631154A (en) * 1988-06-10 1997-05-20 Therion Biologics, Incorporated Self assembled, defective, non-self-propagating lentivirus particles
DE68912441T2 (de) * 1988-06-24 1994-05-11 British Tech Group Nichtessentielle Geflügelpockenvirus-Regionen.
US5093258A (en) * 1988-08-26 1992-03-03 Therion Biologics Corporation Recombinant fowlpox virus and recombination vector
KR940001265B1 (ko) * 1988-12-29 1994-02-18 닛뽕 제온 가부시끼가이샤 프로모터, 그를 함유하는 플라스미드 및 재조합 아비폭스비루스
JP2781605B2 (ja) * 1989-06-22 1998-07-30 日本ゼオン株式会社 組み換えアビポックスウイルス
WO1992000372A1 (en) * 1990-07-02 1992-01-09 Smithkline Beecham Corporation Recombinant pigeon pox virus vaccine
ATE253123T1 (de) * 1991-08-26 2003-11-15 Baxter Healthcare Sa Ein intaktes fpv-tk-gen enthaltender rekombinanter virus der vogelpocken
US5925358A (en) * 1993-02-26 1999-07-20 Syntro Corporation Recombinant fowlpox viruses and uses thereof
US6136318A (en) * 1993-02-26 2000-10-24 Cochran; Mark D. Recombinant fowlpox viruses and uses thereof
EP0696204A4 (en) * 1993-02-26 1999-03-31 Syntro Corp Recombined chickenpox virus and its use
DE69433976T2 (de) * 1993-03-31 2005-09-01 Zeon Corp. Neuartige Polypeptide, ihre DNA, rekombinanter Vektor, der letztere enthält, mit diesem hergestelltes rekombinantes Virus und seine Verwendung
WO1998004727A1 (en) 1996-07-25 1998-02-05 Therion Biologics Corporation Recombinant pox virus for immunization against tumor-associated antigens
CA2351622A1 (en) 1998-11-18 2000-05-25 Oxford Biomedica (Uk) Limited Polypeptide
CA2515890C (en) 2003-02-20 2013-09-17 Therion Biologics Corporation Novel insertion sites in pox vectors
EP1888634A2 (en) 2005-05-13 2008-02-20 Oxford Biomedica (UK) Limited Mhc class i and ii peptide antigens derived from tumour antigen 5t4
EP2397852B1 (en) 2006-03-14 2013-12-04 Oregon Health and Science University Methods for detecting a mycobacterium tuberculosis infection
EP2125868B1 (en) 2007-02-28 2015-06-10 The Govt. Of U.S.A. As Represented By The Secretary Of The Department Of Health And Human Services Brachyury polypeptides and methods for use
US8691502B2 (en) 2008-10-31 2014-04-08 Tremrx, Inc. T-cell vaccination with viral vectors via mechanical epidermal disruption
WO2010099472A2 (en) 2009-02-27 2010-09-02 The U.S.A. Of America, As Represented By The Secretary, Department Of Health And Human Services Spanx-b polypeptides and their use
EP3360566B1 (en) 2009-11-20 2019-12-25 Oregon Health&Science University Methods for detecting a mycobacterium tuberculosis infection
WO2012151272A2 (en) 2011-05-02 2012-11-08 Tremrx, Inc. T-cell vaccination with viral vectors via mechanical epidermal disruption
EP2788021B1 (en) 2011-12-09 2017-01-18 Bavarian Nordic A/S Poxvirus vector for the expression of bacterial antigens linked to tetanus toxin fragment c
WO2014043535A1 (en) 2012-09-14 2014-03-20 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Compositions for the treatment of cancer
HUE051897T2 (hu) 2015-03-18 2021-03-29 Janssen Vaccines & Prevention Bv Vizsgálatok rekombináns expressziós rendszerekre
WO2023077147A2 (en) 2021-11-01 2023-05-04 Pellis Therapeutics, Inc. T-cell vaccines for patients with reduced humoral immunity

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0190254A4 (en) * 1984-07-05 1987-03-09 Genex Corp GENE CLONE AND PROCESS FOR THE PREPARATION AND USE THEREOF.
DE3650289T2 (de) * 1985-03-29 1995-08-10 British Tech Group Spike-protein des virus der infektiösen bronchitis.
AU602875B2 (en) * 1985-12-18 1990-11-01 British Technology Group Limited Newcastle disease virus gene clones
ZA874677B (en) * 1986-06-30 1988-11-30 Smith Kline Rit Dna sequence,recombinant dna molecules and process for producing the newcastle disease virus fusion protein or equivalent polypeptides,obtained products and preparations containing same
WO1988002022A1 (en) * 1986-09-22 1988-03-24 Commonwealth Scientific And Industrial Research Or Recombinant poxviruses
EP0284416B1 (en) * 1987-03-27 1995-02-22 Nippon Zeon Co., Ltd. Recombinant avipoxyvirus
CA1341245C (en) * 1988-01-12 2001-06-05 F. Hoffmann-La Roche Ag Recombinant vaccinia virus mva

Also Published As

Publication number Publication date
KR970000530B1 (ko) 1997-01-13
DE3850019T2 (de) 1994-12-01
CA1340203C (en) 1998-12-15
AU2222888A (en) 1989-03-16
AU611711B2 (en) 1991-06-20
EP0308220B1 (en) 1994-06-08
DE3850019D1 (de) 1994-07-14
EP0308220A1 (en) 1989-03-22

Similar Documents

Publication Publication Date Title
KR890005269A (ko) 재조합 아비폭스비루스
KR890005270A (ko) 재조합 종두 비루스
YU46753B (sh) Rekombinantni virus
DE68922524D1 (de) Herstellung von Bisphenolen.
FR2621487B1 (fr) Virus avipox recombinant
DE68909037D1 (de) Belüftung von Flüssigkeiten.
CL2009002139A1 (es) Peptido sintetico que comprende la secuencia sec id no:6 y sec id no:7 de la proteina gp41 del virus vih con actividad antiretroviral.
DE3685626D1 (de) Sequenzierung von peptiden.
DE3683186D1 (de) Rekombinantes humaninterleukin-1.
ATE63823T1 (de) Pharmazeutische zubereitungsformen zur stabilisierung von interferon alpha.
DE3686130D1 (de) Geschmackskontrolle von proteinhydrolysaten.
ATE140962T1 (de) Dns-klone von menschlichem thrombomodulin
DE3683348D1 (de) Grundiermittel auf basis von polysiloxanen.
IT8347560A0 (it) Polipeptide dotato di attivita' di interferon, composizione che lo con tiene e procedimento di preparazione
DE69005020D1 (de) Bestimmung der Blattsteigung von Propellerblättern.
KR910001061A (ko) 재조합 아비폭스비루스
NO854903L (no) Peptidvaksine eller -diagnosemiddel, samt polypeptid for slik anvendelse.
NO894573D0 (no) Rekombinante interleukin-2 hybridproteiner.
NO892948L (no) Modifiserte proteiner.
DE3886890D1 (de) Herstellung von modifizierten Polysiloxanen.
DE69014171D1 (de) Schwundarm härtbare Zusammensetzung auf Basis von ungesättigten Polyesterbasen.
KR880700073A (ko) 재조합 바이러스
DE68905638D1 (de) Herstellung von alkansulfonylhaliden und alkansulfonsaeuren.
ES2059801T3 (es) Nuevas linfoquinas, secuencias de adn que codifican para estas linfoquinas, y composiciones farmaceuticas conteniendo estas linfoquinas.
USD210407S (en) Light fixture

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
N231 Notification of change of applicant
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20000104

Year of fee payment: 4

LAPS Lapse due to unpaid annual fee